Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

THC and CBD: Similarities and differences between siblings
Nephi Stella
Neuron (2023) Vol. 111, Iss. 3, pp. 302-327
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Mauro Maccarrone, Vincenzo Di Marzo, Jürg Gertsch, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 5, pp. 885-958
Open Access | Times Cited: 72
Inhibiting degradation of 2-arachidonoylglycerol as a therapeutic strategy for neurodegenerative diseases
Chu Chen
Pharmacology & Therapeutics (2023) Vol. 244, pp. 108394-108394
Open Access | Times Cited: 21
Novel rapid treatment options for adolescent depression
Sandra Ledesma‐Corvi, Jordi Jornet-Plaza, Laura Gálvez‐Melero, et al.
Pharmacological Research (2024) Vol. 201, pp. 107085-107085
Open Access | Times Cited: 6
Entourage effects of non-psychotropic cannabinoids (npCBs) on visceral sensitivity in experimental colitis
Kristofer Svendsen, Amyaouch Bradaia, María A. Gandini, et al.
Journal of Pharmacology and Experimental Therapeutics (2025), pp. 103389-103389
Closed Access
Therapeutic potential of cannabidiol polypharmacology in neuropsychiatric disorders
Olivier J. Manzoni, Antonia Manduca, Viviana Trezza
Trends in Pharmacological Sciences (2025)
Open Access
CBD for pets: navigating quality assurance, safety standards, and marketing strategies
Hannah Rideout, A. J. C. Cook, Anthony D. Whetton
Journal of Cannabis Research (2025) Vol. 7, Iss. 1
Open Access
Maladaptive Peripheral Ketogenesis in Schwann Cells Mediated by CB1R Contributes to Diabetic Neuropathy
Weizhen Li, Tuo Yang, Ningning Wang, et al.
Advanced Science (2025)
Open Access
Therapeutic potential of cannabinoids in neurological conditions: a systematic review of clinical trials
Alqassem Y. Hakami, Fahad S. Alshehri
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Select Minor Cannabinoids from Cannabis sativa Are Cannabimimetic and Antinociceptive in a Mouse Model of Chronic Neuropathic Pain
Abigail M. Schwarz, Dea Kobeci, Jessica Mancuso, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 391, Iss. 2, pp. 214-221
Open Access | Times Cited: 5
Anti-inflammatory effects of cannabidiol in early stages of neuroinflammation induced by high-fat diet in cerebral cortex of rats
Aleksandra Opęchowska, Kacper Karpiuk, Andrii Zahorodnii, et al.
Toxicology and Applied Pharmacology (2024) Vol. 484, pp. 116856-116856
Open Access | Times Cited: 3
Δ9-Tetrahydrocannabinol (THC): A Critical Overview of Recent Clinical Trials and Suggested Guidelines for Future Research
Peter Pressman, A. Wallace Hayes, Julia Hoeng, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 6, pp. 1540-1540
Open Access | Times Cited: 3
The role of cannabidiol in aging
Beibei Ni, Yanying Liu, Meng Dai, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115074-115074
Open Access | Times Cited: 10
A lactate-dependent shift of glycolysis mediates synaptic and cognitive processes in male mice
Ignacio Fernández‐Moncada, Gianluca Lavanco, Unai B. Fundazuri, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Cannabidiol usage, efficacy, and side effects: analyzing the impact of health conditions, medications, and cannabis use in a cross-sectional online pilot study
Alicja Anna Binkowska, Natalia Jakubowska, Anna Redeł, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 2
Therapeutic potentials of cannabidiol: Focus on the Nrf2 signaling pathway
Marjan Talebi, Mohammad Mehdi Sadoughi, Seyed Abdulmajid Ayatollahi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115805-115805
Open Access | Times Cited: 7
An enquiry to the role of CB1 receptors in neurodegeneration
Ignacio Fernández‐Moncada, Abel Eraso‐Pichot, Tommaso Dalla Tor, et al.
Neurobiology of Disease (2023) Vol. 184, pp. 106235-106235
Open Access | Times Cited: 6
Type‐1 cannabinoid receptors and their ever‐expanding roles in brain energy processes
Ignacio Fernández‐Moncada, Rui S. Rodrigues, Unai B. Fundazuri, et al.
Journal of Neurochemistry (2023) Vol. 168, Iss. 5, pp. 693-703
Open Access | Times Cited: 6
Involvement of CKS1B in the anti-inflammatory effects of cannabidiol in experimental stroke models
Kechun Chen, Bingtian Xu, Xuan Xiao, et al.
Experimental Neurology (2023) Vol. 373, pp. 114654-114654
Closed Access | Times Cited: 5
Inhibition of cannabinoid degradation enhances hippocampal contextual fear memory and exhibits anxiolytic effects
Jinming Zhang, Junmin Zhang, Ruiqi Yuan, et al.
iScience (2024) Vol. 27, Iss. 2, pp. 108919-108919
Open Access | Times Cited: 1
Beneficial effects of cannabidiol from Cannabis
Sullim Lee, Yunjeong Lee, Yun-Seo Kim, et al.
Applied Biological Chemistry (2024) Vol. 67, Iss. 1
Open Access | Times Cited: 1
Differential effects of cannabis constituents on schizophrenia-related psychosis: a rationale for incorporating cannabidiol into a schizophrenia therapeutic regimen
Kennadi Johnson, Abby J. Weldon, Melissa A. Burmeister
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 1
Analgesic Properties of Next-Generation Modulators of Endocannabinoid Signaling: Leveraging Modern Tools for the Development of Novel Therapeutics
Simar Singh, Kaylin J. Ellioff, Michael R. Bruchas, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 391, Iss. 2, pp. 162-173
Closed Access | Times Cited: 1
Toxicological mechanism of cannabidiol (CBD) exposure on zebrafish embryonic development
Ying Wei, Xiqi Chen, Yue Li, et al.
Food and Chemical Toxicology (2024) Vol. 193, pp. 114929-114929
Closed Access | Times Cited: 1
Exploratory survey study on adjunctive use of medical cannabis for Gaucher disease
Yehoshua Berman, Robin J. Ely, Yosef Y. Scher, et al.
Rare Disease and Orphan Drugs Journal (2024) Vol. 3, Iss. 3
Open Access | Times Cited: 1
Cannabidiol Alleviates Imiquimod-Induced Psoriasis by Inhibiting JAK2–STAT3 in a Mouse Model
Minseo Kim, Ji Hyun Lee, Sae-Woong Kim, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 2084-2084
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top